240 related articles for article (PubMed ID: 10079252)
1. Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression.
Kageshita T; Hirai S; Ono T; Hicklin DJ; Ferrone S
Am J Pathol; 1999 Mar; 154(3):745-54. PubMed ID: 10079252
[TBL] [Abstract][Full Text] [Related]
2. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
[TBL] [Abstract][Full Text] [Related]
3. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors.
Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT
Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701
[TBL] [Abstract][Full Text] [Related]
4. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.
Kamarashev J; Ferrone S; Seifert B; Böni R; Nestle FO; Burg G; Dummer R
Int J Cancer; 2001 Jan; 95(1):23-8. PubMed ID: 11241306
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S
Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289
[TBL] [Abstract][Full Text] [Related]
7. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity.
Tao J; Li Y; Liu YQ; Wang L; Yang J; Dong J; Wu Y; Shen GX; Tu YT
J Invest Dermatol; 2008 Aug; 128(8):1991-6. PubMed ID: 18385764
[TBL] [Abstract][Full Text] [Related]
8. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules.
Arnold D; Driscoll J; Androlewicz M; Hughes E; Cresswell P; Spies T
Nature; 1992 Nov; 360(6400):171-4. PubMed ID: 1436094
[TBL] [Abstract][Full Text] [Related]
9. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines.
Johnsen A; France J; Sy MS; Harding CV
Cancer Res; 1998 Aug; 58(16):3660-7. PubMed ID: 9721876
[TBL] [Abstract][Full Text] [Related]
11. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
Singal DP; Ye M; Ni J; Snider DP
Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases.
Müller M; Agaimy A; Zenk J; Ettl T; Iro H; Hartmann A; Seliger B; Schwarz S
Histopathology; 2013 May; 62(6):847-59. PubMed ID: 23611358
[TBL] [Abstract][Full Text] [Related]
13. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.
Vitale M; Rezzani R; Rodella L; Zauli G; Grigolato P; Cadei M; Hicklin DJ; Ferrone S
Cancer Res; 1998 Feb; 58(4):737-42. PubMed ID: 9485029
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
[TBL] [Abstract][Full Text] [Related]
15. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
16. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
17. Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport.
Cerundolo V; Kelly A; Elliott T; Trowsdale J; Townsend A
Eur J Immunol; 1995 Feb; 25(2):554-62. PubMed ID: 7875220
[TBL] [Abstract][Full Text] [Related]
18. The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer.
Fellerhoff B; Gu S; Laumbacher B; Nerlich AG; Weiss EH; Glas J; Kopp R; Johnson JP; Wank R
Cancer Res; 2011 Dec; 71(23):7145-54. PubMed ID: 22037870
[TBL] [Abstract][Full Text] [Related]
19. Association of TAP and HLA-DM genes with psoriasis in Koreans.
Pyo CW; Hur SS; Kim YK; Kim TY; Kim TG
J Invest Dermatol; 2003 Apr; 120(4):616-22. PubMed ID: 12648225
[TBL] [Abstract][Full Text] [Related]
20. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
